Abstract
Enhanced activity of haemodynamic hormones have been reported to be involved in the development of renal lesions of diabetic kidney1,2. Apart from other pressor factors even plasma arginine-vasopressin (AVP) have been found to be increased in uncontrolled diabetic patients very probably reflecting both a hypovolemic status and an increase in “effective” extracellular fluid osmolality; however, high circulating AVP levels have also been observed in certain well controlled diabetic patients thus suggesting that an alteration of mechanisms regulating AVP secretion exists in diabetes mellitus3,4.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
SCHOR N., ICHIKAWA I. and BRENNER B. M.: Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int., 20, 442–451, 1981.
BOHRER M. P., DEEN W. M., ROBERTSON C. R., BRENNER B. M.: Mechanism of angiotensin II induced proteinuria in the rat. Am. J. Physiol., 233, F 13 - F 19, 1977.
ZERBE R. L., VINICOR F. and ROBERTSON G. L.: Regulation of plasma vasopressin in insulin-dependent diabetes mellitus. Am. J. Physiol., 249, E 317 - E 325, 1985.
ZERBE R. L., VINICOR F. and ROBERTSON G. L.: Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28, 503–508,May 1979.
ICHIKAWA I. and BRENNER B. M.: Evidence for glomerular action of ADH and dibutyryl cyclic AMP in the rat. Am. J. Physiol., 233, 102–117, 1977.
MYERS B. D., WINETZ J. A., CHUI F. and MICHAELS A. S.: Mechanism of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney Int., 21, 633–636, 1982.
DE FRONZO R. A.: The effect of insulin on sodium metabolism. A review with clinical implications. Diabetologia 21, 165–171, 1981.
WEITZMAN R. E., FISHER D. A., DI STEFANO J. J., BENNET C.M.: Episodic secretion of arginine vasopressin. Am. J. Physiol., 233, E 32 - E 39, 1977.
SCHRIER R. W., BERL T. and ANDERSON R. S.: Osmotic and nonosmotic control of vasopressin release. Am. J. Physiol., 236 (4), F 321 - F 332, 1979.
KHOKHAR A. M., SLATER J. D. H., FORSLING M. L. and RAMAGE C. M.: The physiological significance of urinary vasopressin and its relationship to plasma levels in man. Clin. Sci. Mol. Med., 49, 14–15, 1975 b.
TAUSCH A., STEGNER H., LEAKE R. D., ARTMAN H. G., and FISHER D. A.: Radioimmunoassay of arginin vasopressin in urine. Development and application. J. Clin. Endocrinol. Metab., 57, 777–781, 1983.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039–1057, 1979.
ROBERTSON G. L. and ATHAR S.: The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J. Clin. Endocrinol. Metab., 42, 613–620, 1976.
BONJOUR J. P. and MALVIN R. L.: Stimulation of ADH release by the renin-angiotensin system. Am. J. Phisiol., 218, 1555–1559, 1970.
RASMUSSEN B. F., MATHIESEN E. R., DECKERT T., GIESE J.,CHRISTENSEN N. S., BENT-HANSEN L. and NIELSEN M. D.: Central role for sodium in the pathogenesis of blood pressure changes indipendent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia., 30, 610–617, 1987.
MAXWELL D., Mc MURRAY S., SZWED J., SHELTON R. and ROBERTSON G.: The effect of distribution and clearance on plasma of vasopressin in man. Clin. Res., 24, 407 A, 1976.
WILLIAMS R. H.: Textbook of Endocrinology Philadelphia. W. B. SAUNDERS, 1974, p. 84.
MOGENSEN C. E.: Maximum tubular reabsorption capacity for gluocose and renal haemodynamics during rapid hypertonic glucose in normal and diabetic subjects. Scan. J. Clin. Lab. Invest., 28, 101–107, 1971.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Narelli, G.M. et al. (1989). Renal Excretion of Arginine-Vasopressin in Microalbuminuric Diabetic Patients. In: Amerio, A., Coratelli, P., Campese, V.M., Massry, S.G. (eds) Drugs, Systemic Diseases, and the Kidney. Advances in Experimental Medicine and Biology, vol 252. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8953-8_39
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8953-8_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8955-2
Online ISBN: 978-1-4684-8953-8
eBook Packages: Springer Book Archive